{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:30:40Z","timestamp":1792200640781,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11427-015-4836-1","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T20:18:51Z","timestamp":1428697131000},"page":"328-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Protein prenylation and human diseases: a balance of protein farnesylation and geranylgeranylation"],"prefix":"10.1007","volume":"58","author":[{"given":"Na","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiuXing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChaoJun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"4836_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","volume":"63","author":"S McTaggart","year":"2006","unstructured":"McTaggart S. Isoprenylated proteins. Cell Mol Life Sci, 2006, 63: 255\u2013267","journal-title":"Cell Mol Life Sci"},{"key":"4836_CR2","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.2741\/2401","volume":"12","author":"D Perez-Sala","year":"2007","unstructured":"Perez-Sala D. Protein isoprenylation in biology and disease: general overview and perspectives from studies with genetically engineered animals. Front Biosci, 2007, 12: 4456\u20134472","journal-title":"Front Biosci"},{"key":"4836_CR3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1104\/pp.007138","volume":"130","author":"M Rodr\u00edguez-Concepci\u00f3n","year":"2002","unstructured":"Rodr\u00edguez-Concepci\u00f3n M, Boronat A. Elucidation of the methylerythritol phosphate pathway for isoprenoid biosynthesis in bacteria and plastids. A metabolic milestone achieved through genomics. Plant Physiol, 2002, 130: 1079\u20131089","journal-title":"Plant Physiol"},{"key":"4836_CR4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00018-004-3381-z","volume":"61","author":"W Eisenreich","year":"2004","unstructured":"Eisenreich W, Bacher A, Arigoni D, Rohdich F. Biosynthesis of isoprenoids via the non-mevalonate pathway. Cell Mol Life Sci, 2004, 61: 1401\u20131426","journal-title":"Cell Mol Life Sci"},{"key":"4836_CR5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-arplant-050312-120116","volume":"64","author":"E Vranov\u00e1","year":"2013","unstructured":"Vranov\u00e1 E, Coman D, Gruissem W. Network analysis of the MVA and MEP pathways for isoprenoid synthesis. Ann Rev Plant Biol, 2013, 64: 665\u2013700","journal-title":"Ann Rev Plant Biol"},{"key":"4836_CR6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/gb-2003-4-4-212","volume":"4","author":"S Maurer-Stroh","year":"2003","unstructured":"Maurer-Stroh S, Washietl S, Eisenhaber F. Protein prenyltransferases. Genome Biol, 2003, 4: 212","journal-title":"Genome Biol"},{"key":"4836_CR7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc3151","volume":"11","author":"N Berndt","year":"2011","unstructured":"Berndt N, Hamilton AD, Sebti SM. Targeting protein prenylation for cancer therapy. Nat Rev Cancer, 2011, 11: 775\u2013791","journal-title":"Nat Rev Cancer"},{"key":"4836_CR8","first-page":"1905","volume":"10","author":"JM Carboni","year":"1995","unstructured":"Carboni JM, Yan N, Cox AD, Bustelo X, Graham SM, Lynch MJ, Weinmann R, Seizinger BR, Der CJ, Barbacid M. Farnesyltransferase inhibitors are inhibitors of ras but not r-ras2\/tc21, transformation. Oncogene, 1995, 10: 1905\u20131913","journal-title":"Oncogene"},{"key":"4836_CR9","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1074\/jbc.272.22.14459","volume":"272","author":"DB Whyte","year":"1997","unstructured":"Whyte DB, Kirschmeier P, Hockenberry TN, Nunez-Oliva I, James L, Catino JJ, Bishop WR, Pai J-K. K-and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J Biol Chem, 1997, 272: 14459\u201314464","journal-title":"J Biol Chem"},{"key":"4836_CR10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer, 2003, 3: 11\u201322","journal-title":"Nat Rev Cancer"},{"key":"4836_CR11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2005.03.004","volume":"7","author":"N Mijimolle","year":"2005","unstructured":"Mijimolle N, Velasco J, Dubus P, Guerra C, Weinbaum CA, Casey PJ, Campuzano V, Barbacid M. Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development. Cancer Cell, 2005, 7: 313\u2013324","journal-title":"Cancer Cell"},{"key":"4836_CR12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1172\/JCI30868","volume":"117","author":"AK Sjogren","year":"2007","unstructured":"Sjogren AK, Andersson KM, Liu M, Cutts BA, Karlsson C, Wahlstrom AM, Dalin M, Weinbaum C, Casey PJ, Tarkowski A, Swolin B, Young SG, Bergo MO. GGTase-I deficiency reduces tumor formation and improves survival in mice with K-Ras-induced lung cancer. J Clin Invest, 2007, 117: 1294\u20131304","journal-title":"J Clin Invest"},{"key":"4836_CR13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1172\/JCI43758","volume":"121","author":"OM Khan","year":"2011","unstructured":"Khan OM, Ibrahim MX, Jonsson IM, Karlsson C, Liu M, Sjogren AK, Olofsson FJ, Brisslert M, Andersson S, Ohlsson C, Hulten LM, Bokarewa M, Bergo MO. Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice. J Clin Invest, 2011, 121: 628\u2013639","journal-title":"J Clin Invest"},{"key":"4836_CR14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/mgme.1998.2729","volume":"65","author":"V Shotelersuk","year":"1998","unstructured":"Shotelersuk V, Gahl WA. Hermansky-pudlak syndrome: models for intracellular vesicle formation. Mol Genet Metab, 1998, 65: 85\u201396","journal-title":"Mol Genet Metab"},{"key":"4836_CR15","doi-asserted-by":"crossref","first-page":"46798","DOI":"10.1074\/jbc.M307799200","volume":"278","author":"B Larijani","year":"2003","unstructured":"Larijani B, Hume AN, Tarafder AK, Seabra MC. Multiple factors contribute to inefficient prenylation of Rab27a in Rab prenylation diseases. J Biol Chem, 2003, 278: 46798\u201346804","journal-title":"J Biol Chem"},{"key":"4836_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(01)02483-8","volume":"498","author":"JB Pereira-Leal","year":"2001","unstructured":"Pereira-Leal JB, Hume AN, Seabra MC. Prenylation of rab GTPases: molecular mechanisms and involvement in genetic disease. FEBS Lett, 2001, 498: 197\u2013200","journal-title":"FEBS Lett"},{"key":"4836_CR17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2011.09.056","volume":"50","author":"MM Weivoda","year":"2012","unstructured":"Weivoda MM, Hohl RJ. Geranylgeranyl pyrophosphate stimulates PPAR\u03b3 expression and adipogenesis through the inhibition of osteoblast differentiation. Bone, 2012, 50: 467\u2013476","journal-title":"Bone"},{"key":"4836_CR18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jcb.23087","volume":"112","author":"MM Weivoda","year":"2011","unstructured":"Weivoda MM, Hohl RJ. The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation. J Cell Biochem, 2011, 112: 1506\u20131513","journal-title":"J Cell Biochem"},{"key":"4836_CR19","doi-asserted-by":"crossref","first-page":"L1297","DOI":"10.1152\/ajplung.00194.2006","volume":"292","author":"CJ Li","year":"2007","unstructured":"Li CJ, Ning W, Matthay MA, Feghali-Bostwick CA, Choi AM. MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production. Am J Physiol-Lung Cell Mol Physiol, 2007, 292: L1297\u20131303","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"4836_CR20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1165\/rcmb.2006-0106OC","volume":"36","author":"W Ning","year":"2007","unstructured":"Ning W, Dong Y, Sun J, Li C, Matthay MA, Feghali-Bostwick CA, Choi AM. Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts. Am J Resp Cell Mol Biol, 2007, 36: 480","journal-title":"Am J Resp Cell Mol Biol"},{"key":"4836_CR21","doi-asserted-by":"crossref","first-page":"14895","DOI":"10.1073\/pnas.0401168101","volume":"101","author":"W Ning","year":"2004","unstructured":"Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA, 2004, 101: 14895\u201314900","journal-title":"Proc Natl Acad Sci USA"},{"key":"4836_CR22","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.ajpath.2011.08.011","volume":"179","author":"N Shen","year":"2011","unstructured":"Shen N, Shao Y, Lai SS, Qiao L, Yang RL, Xue B, Pan FY, Chen HQ, Li CJ. GGPPS, a new EGR-1 target gene, reactivates ERK 1\/2 signaling through increasing ras prenylation. Am J Pathol, 2011, 179: 2740\u20132750","journal-title":"Am J Pathol"},{"key":"4836_CR23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2010.04.102","volume":"396","author":"H Chen","year":"2010","unstructured":"Chen H, Wang L, Gong T, Yu Y, Zhu C, Li F, Wang L, Li C. EGR-1 regulates Ho-1 expression induced by cigarette smoke. Biochem Biophys Res Commun, 2010, 396: 388\u2013393","journal-title":"Biochem Biophys Res Commun"},{"key":"4836_CR24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajpath.2010.11.016","volume":"178","author":"N Shen","year":"2011","unstructured":"Shen N, Gong T, Wang JD, Meng FL, Qiao L, Yang RL, Xue B, Pan FY, Zhou XJ, Chen HQ, Ning W, Li CJ. Cigarette smoke-induced pulmonary inflammatory responses are mediated by EGR-1\/GGPPS\/MAPK signaling. Am J Pathol, 2011, 178: 110\u2013118","journal-title":"Am J Pathol"},{"key":"4836_CR25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature, 2006, 444: 860\u2013867","journal-title":"Nature"},{"key":"4836_CR26","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/MCB.20.6.2158-2166.2000","volume":"20","author":"D Vicent","year":"2000","unstructured":"Vicent D, Maratos-Flier E, Kahn CR. The branch point enzyme of the mevalonate pathway for protein prenylation is overexpressed in the ob\/ob mouse and induced by adipogenesis. Mol Cell Biol, 2000, 20: 2158\u20132166","journal-title":"Mol Cell Biol"},{"key":"4836_CR27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.ijo.0802189","volume":"27","author":"C Solomon","year":"2003","unstructured":"Solomon C, Leitner J, Goalstone M. Dominant negative \u03b1-subunit of farnesyl-and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes. Int J Obes Relat Metab Disord, 2003, 27: 40\u201347","journal-title":"Int J Obes Relat Metab Disord"},{"key":"4836_CR28","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1074\/jbc.M110.190165","volume":"286","author":"N Shen","year":"2011","unstructured":"Shen N, Yu X, Pan FY, Gao X, Xue B, Li CJ. An early response transcription factor, EGR-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism. J Biol Chem, 2011, 286: 14508\u201314515","journal-title":"J Biol Chem"},{"key":"4836_CR29","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/emboj.2011.277","volume":"30","author":"X Yu","year":"2011","unstructured":"Yu X, Shen N, Zhang ML, Pan FY, Wang C, Jia WP, Liu C, Gao Q, Gao X, Xue B, Li CJ. EGR-1 decreases adipocyte insulin sensitivity by tilting PI3K\/Akt and MAPK signal balance in mice. EMBO J, 2011, 30: 3754\u20133765","journal-title":"EMBO J"},{"key":"4836_CR30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrg1381","volume":"5","author":"J Brennan","year":"2004","unstructured":"Brennan J, Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet, 2004, 5: 509\u2013521","journal-title":"Nat Rev Genet"},{"key":"4836_CR31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0074-7696(00)00002-4","volume":"200","author":"S Mackay","year":"2000","unstructured":"Mackay S. Gonadal development in mammals at the cellular and molecular levels. Int Rev Cytol, 2000, 200: 47\u201399","journal-title":"Int Rev Cytol"},{"key":"4836_CR32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1464-410X.2006.05902.x","volume":"97","author":"J Philip","year":"2006","unstructured":"Philip J, Selvan D, Desmond AD. Mumps orchitis in the non-immune postpubertal male: a resurgent threat to male fertility? BJU Int, 2006, 97: 138\u2013141","journal-title":"BJU Int"},{"key":"4836_CR33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/978-0-387-09597-4_12","volume":"636","author":"BP Setchell","year":"2008","unstructured":"Setchell BP. Blood-testis barrier, junctional and transport proteins and spermatogenesis. Adv Exp Med Biol, 2008, 636: 212\u2013233","journal-title":"Adv Exp Med Biol"},{"key":"4836_CR34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000094142","volume":"66","author":"C Petersen","year":"2006","unstructured":"Petersen C, S\u00f6der O. The sertoli cell\u2014a hormonal target and \u2018super\u2019nurse for germ cells that determines testicular size. Horm Res Paediatr, 2006, 66: 153\u2013161","journal-title":"Horm Res Paediatr"},{"key":"4836_CR35","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1210\/en.2009-1498","volume":"151","author":"B Sun","year":"2010","unstructured":"Sun B, Qi N, Shang T, Wu H, Deng T, Han D. Sertoli cell-initiated testicular innate immune response through toll-like receptor-3 activation is negatively regulated by Tyro3, Axl, and mer receptors. Endocrinology, 2010, 151: 2886\u20132897","journal-title":"Endocrinology"},{"key":"4836_CR36","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.4049\/jimmunol.177.10.7122","volume":"177","author":"A Riccioli","year":"2006","unstructured":"Riccioli A, Starace D, Galli R, Fuso A, Scarpa S, Palombi F, De Cesaris P, Ziparo E, Filippini A. Sertoli cells initiate testicular innate immune responses through TLR activation. J Immunol, 2006, 177: 7122\u20137130","journal-title":"J Immunol"},{"key":"4836_CR37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.20121806","volume":"210","author":"XX Wang","year":"2013","unstructured":"Wang XX, Ying P, Diao F, Wang Q, Ye D, Jiang C, Shen N, Xu N, Chen WB, Lai SS, Jiang S, Miao XL, Feng J, Tao WW, Zhao NW, Yao B, Xu ZP, Sun HX, Li JM, Sha JH, Huang XX, Shi QH, Tang H, Gao X, Li CJ. Altered protein prenylation in sertoli cells is associated with adult infertility resulting from childhood mumps infection. J Exp Med, 2013, 210: 1559\u20131574","journal-title":"J Exp Med"},{"key":"4836_CR38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jhep.2009.10.010","volume":"52","author":"J Frith","year":"2010","unstructured":"Frith J, Day CP, Robinson L, Elliott C, Jones DE, Newton JL. Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease. J Hepatol, 2010, 52: 112\u2013116","journal-title":"J Hepatol"},{"key":"4836_CR39","first-page":"067","volume":"5","author":"L Wang","year":"2010","unstructured":"Wang L, Shen ZH, Xu Q. Study on the prevalence of nonalcoholic fatty liver and the association between nonalcoholic fatty liver and metabolic syndrome. Chin J Convalesc Med, 2010, 5: 067","journal-title":"Chin J Convalesc Med"},{"key":"4836_CR40","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","volume":"92","author":"A Kotronen","year":"2007","unstructured":"Kotronen A, Westerbacka J, Bergholm R, Pietil\u00e4inen KH, Yki-J\u00e4rvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab, 2007, 92: 3490\u20133497","journal-title":"J Clin Endocrinol Metab"},{"key":"4836_CR41","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology, 2003, 37: 1202\u20131219","journal-title":"Hepatology"},{"key":"4836_CR42","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","volume":"113","author":"M Watanabe","year":"2004","unstructured":"Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest, 2004, 113: 1408\u20131418","journal-title":"J Clin Invest"},{"key":"4836_CR43","doi-asserted-by":"crossref","first-page":"23173","DOI":"10.1074\/jbc.270.39.23173","volume":"270","author":"J Hunter","year":"1995","unstructured":"Hunter J, Tanaka N, Rockman H, Ross J, Chien K. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem, 1995, 270: 23173","journal-title":"J Biol Chem"},{"key":"4836_CR44","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI6842","volume":"103","author":"VP Sah","year":"1999","unstructured":"Sah VP, Minamisawa S, Tam SP, Wu TH, Dorn GW, Ross J, Chien KR, Brown JH. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure. J Clin Invest, 1999, 103: 1627\u20131634","journal-title":"J Clin Invest"},{"key":"4836_CR45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin J. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol, 2006, 7: 589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4836_CR46","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S1462399411001931","volume":"13","author":"KE Porter","year":"2011","unstructured":"Porter KE, Turner NA. Statins and myocardial remodelling: cell and molecular pathways. Expert Rev Mol Med, 2011, 13: e22","journal-title":"Expert Rev Mol Med"},{"key":"4836_CR47","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1074\/jbc.M310081200","volume":"279","author":"MO Bergo","year":"2004","unstructured":"Bergo MO, Lieu HD, Gavino BJ, Ambroziak P, Otto JC, Casey PJ, Walker QM, Young SG. On the physiological importance of endoproteolysis of CAAX proteins. J Biol Chem, 2004, 279: 4729","journal-title":"J Biol Chem"},{"key":"4836_CR48","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/cvr\/cvs347","volume":"97","author":"J Yang","year":"2013","unstructured":"Yang J, Mou Y, Wu T, Ye Y, Jiang JC, Zhao CZ, Zhu HH, Du CQ, Zhou L, Hu SJ. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice. Cardiovasc Res, 2013, 97: 490\u2013499","journal-title":"Cardiovasc Res"},{"key":"4836_CR49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bcp.2009.08.033","volume":"79","author":"L Li","year":"2010","unstructured":"Li L, Chen G, Yang Y, Ye Y, Yao L, Hu S. Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats. Biochem Pharmacol, 2010, 79: 399\u2013406","journal-title":"Biochem Pharmacol"},{"key":"4836_CR50","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.1127704","volume":"313","author":"P Yi","year":"2006","unstructured":"Yi P, Han Z, Li X, Olson E. The mevalonate pathway controls heart formation in Drosophila by isoprenylation of Ggamma 1. Science, 2006, 313: 1301","journal-title":"Science"},{"key":"4836_CR51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIR.0b013e318282ab8f","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics C, Stroke Statistics S. Executive summary: heart disease and stroke statistics\u20142013 update: a report from the american heart association. Circulation, 2013, 127: 143\u2013152","journal-title":"Circulation"},{"key":"4836_CR52","volume-title":"J Pathol","author":"N Xu","year":"2014","unstructured":"Xu N, Guan S, Chen Z, Yu Y, Xie J, Pan FY, Zhao NW, Liu L, Yang ZZ, Gao X, Xu B, Li CJ. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure. J Pathol, 2014, doi: 10.1002\/path.4480"},{"key":"4836_CR53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1194\/jlr.R600002-JLR200","volume":"47","author":"KT Lane","year":"2006","unstructured":"Lane KT, Beese LS. Thematic review series: lipid posttranslational modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I. J Lipid Res, 2006, 47: 681\u2013699","journal-title":"J Lipid Res"},{"key":"4836_CR54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0022-2275(20)30180-2","volume":"43","author":"PA Edwards","year":"2002","unstructured":"Edwards PA, Kast HR, Anisfeld AM. Bareing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res, 2002, 43: 2\u201312","journal-title":"J Lipid Res"},{"key":"4836_CR55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.physiol.68.033104.152158","volume":"68","author":"NY Kalaany","year":"2006","unstructured":"Kalaany NY, Mangelsdorf DJ. LXRS and FXR: The yin and yang of cholesterol and fat metabolism. Ann Rev Physiol, 2006, 68: 159\u2013191","journal-title":"Ann Rev Physiol"},{"key":"4836_CR56","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bone.2011.08.013","volume":"49","author":"H Id Boufker","year":"2011","unstructured":"Id Boufker H, Lagneaux L, Fayyad-Kazan H, Badran B, Najar M, Wiedig M, Ghanem G, Laurent G, Body JJ, Journ\u00e9 F. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts. Bone, 2011, 49: 1219\u20131231","journal-title":"Bone"},{"key":"4836_CR57","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1755-5922.2008.00062.x","volume":"26","author":"J Be\u0142towski","year":"2008","unstructured":"Be\u0142towski J. Liver X receptors (LXR) as therapeutic targets in dyslipidemia. Cardiovasc Ther, 2008, 26: 297\u2013316","journal-title":"Cardiovasc Ther"},{"key":"4836_CR58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature05449","volume":"445","author":"N Mitro","year":"2006","unstructured":"Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V, Kreusch A, Saez E. The nuclear receptor LXR is a glucose sensor. Nature, 2006, 445: 219\u2013223","journal-title":"Nature"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-015-4836-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-015-4836-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-015-4836-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T20:39:09Z","timestamp":1651696749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-015-4836-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["4836"],"URL":"https:\/\/doi.org\/10.1007\/s11427-015-4836-1","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}